For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Treatment (Selumetinib) | Patients receive selumetinib PO BID for 3 weeks. Courses repeat every 3 weeks in the absence of disease progression or unacceptable toxicity. Laboratory Biomarker Analysis: Correlative studies Selumetinib: Given PO | None | None | 17 | 28 | 28 | 28 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| hypothyroidism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | NCI CTCAE V 3.0 | View |
| SGPT | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| Fistula | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| Abdominal Pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| pulmonary / URT infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE V 3.0 | View |
| malignant ascites | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| ileus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| SGOT | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| confusion | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE V 3.0 | View |
| fatigue | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE V 3.0 | View |
| mental status changes | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE V 3.0 | View |
| fatal progressive disease | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | NCI CTCAE V 3.0 | View |
| dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE V 3.0 | View |
| increased intraocular pressure | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE V 3.0 | View |
| dry skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V 3.0 | View |
| blurry vision | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE V 3.0 | View |
| skin infection | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V 3.0 | View |
| joint pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE V 3.0 | View |
| muscle pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE V 3.0 | View |
| hypoalbuminemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| retinopathy | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE V 3.0 | View |
| dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE V 3.0 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| fever (without neutropenia) | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE V 3.0 | View |
| lymphopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE V 3.0 | View |
| platelets | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE V 3.0 | View |
| hypertension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI CTCAE V 3.0 | View |
| INR | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE V 3.0 | View |
| PTT | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE V 3.0 | View |
| fatigue | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE V 3.0 | View |
| insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE V 3.0 | View |
| dry skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V 3.0 | View |
| nail changes | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V 3.0 | View |
| pruritis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V 3.0 | View |
| rash/desquamation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V 3.0 | View |
| rash: acneiform | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V 3.0 | View |
| rash: erythema multiforme | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V 3.0 | View |
| skin - other | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V 3.0 | View |
| anorexia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| dry mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| fistula | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| mucositis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| taste disturbance | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| hemorrhage - anus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| hemorrhage - nose | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE V 3.0 | View |
| edema - head and neck | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE V 3.0 | View |
| edema - limb | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE V 3.0 | View |
| edema - trunk | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE V 3.0 | View |
| hypoalbuminemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| alkaline phosphatase | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| SGPT | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| SGOT | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| bicarbonate | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| bilirubin | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| hypocalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| hypercholesterolemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| creatinine | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| hyperglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| hypoglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| hypermagnesemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| hypomagnesemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| hypophosphatemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| hyperkalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| hypokalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| hyponatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE V 3.0 | View |
| depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE V 3.0 | View |
| neuropathy - sensory | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE V 3.0 | View |
| tearing | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE V 3.0 | View |
| abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE V 3.0 | View |
| extremity - limb pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE V 3.0 | View |
| headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE V 3.0 | View |
| joint pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE V 3.0 | View |
| cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE V 3.0 | View |
| dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE V 3.0 | View |
| voice changes/ dysarthria | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE V 3.0 | View |
| infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE V 3.0 | View |
| other | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V 3.0 | View |
| other | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V 3.0 | View |
| other | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE V 3.0 | View |
| other | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE V 3.0 | View |
| other | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE V 3.0 | View |
| allergic rhinitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE V 3.0 | View |
| tinnitus | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | NCI CTCAE V 3.0 | View |
| hemoglobin - low | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE V 3.0 | View |
| leukocytes | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE V 3.0 | View |